GOSS Gossamer Bio Inc

Wedbush analyst Andreas Argyrides maintained a Buy rating on Gossamer Bio (GOSS - Research Report) today and set a price target of $19.00. The company's shares closed yesterday at $9.12.Argyrides covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical, Ascendis Pharma, and Albireo Pharma. According to TipRanks, Argyrides has an average return of -9.5% and a 43.64% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Gossamer Bio with a $18.33 average price target, a 100.99% upside from current levels.
https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-gossamer-bio-goss-2?utm_source=advfn.com&utm_medium=referral